Unknown

Dataset Information

0

Identification of potential inhibitors of Mycobacterium tuberculosis shikimate kinase: molecular docking, in silico toxicity and in vitro experiments.


ABSTRACT: Tuberculosis (TB) is one of the main causes of death from a single pathological agent, Mycobacterium tuberculosis (Mtb). In addition, the emergence of drug-resistant TB strains has exacerbated even further the treatment outcome of TB patients. It is thus needed the search for new therapeutic strategies to improve the current treatment and to circumvent the resistance mechanisms of Mtb. The shikimate kinase (SK) is the fifth enzyme of the shikimate pathway, which is essential for the survival of Mtb. The shikimate pathway is absent in humans, thereby indicating SK as an attractive target for the development of anti-TB drugs. In this work, a combination of in silico and in vitro techniques was used to identify potential inhibitors for SK from Mtb (MtSK). All compounds of our in-house database (Centro de Pesquisas em Biologia Molecular e Funcional, CPBMF) were submitted to in silico toxicity analysis to evaluate the risk of hepatotoxicity. Docking experiments were performed to identify the potential inhibitors of MtSK according to the predicted binding energy. In vitro inhibitory activity of MtSK-catalyzed chemical reaction at a single compound concentration was assessed. Minimum inhibitory concentration values for in vitro growth of pan-sensitive Mtb H37Rv strain were also determined. The mixed approach implemented in this work was able to identify five compounds that inhibit both MtSK and the in vitro growth of Mtb.

SUBMITTER: Freitas de Freitas T 

PROVIDER: S-EPMC9772590 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Identification of potential inhibitors of Mycobacterium tuberculosis shikimate kinase: molecular docking, in silico toxicity and in vitro experiments.

Freitas de Freitas Talita T   Roth Candida Deves CD   Abbadi Bruno Lopes BL   Hopf Fernanda Souza Macchi FSM   Perelló Marcia Alberton MA   de Matos Czeczot Alexia A   de Souza Eduardo Vieira EV   Borsoi Ana Flávia AF   Machado Pablo P   Bizarro Cristiano Valim CV   Basso Luiz Augusto LA   Timmers Luis Fernando Saraiva Macedo LFSM  

Journal of computer-aided molecular design 20221222 3


Tuberculosis (TB) is one of the main causes of death from a single pathological agent, Mycobacterium tuberculosis (Mtb). In addition, the emergence of drug-resistant TB strains has exacerbated even further the treatment outcome of TB patients. It is thus needed the search for new therapeutic strategies to improve the current treatment and to circumvent the resistance mechanisms of Mtb. The shikimate kinase (SK) is the fifth enzyme of the shikimate pathway, which is essential for the survival of  ...[more]

Similar Datasets

| S-EPMC4362912 | biostudies-literature
| S-EPMC11215815 | biostudies-literature
| S-EPMC2330112 | biostudies-literature
| S-EPMC8541300 | biostudies-literature
| S-EPMC3646032 | biostudies-literature
| S-EPMC3093739 | biostudies-literature
| S-EPMC6314710 | biostudies-literature
| S-EPMC7993393 | biostudies-literature
| S-EPMC7144000 | biostudies-literature
| S-EPMC2789096 | biostudies-literature